Protalix BioTherapeutics, Inc. (NYSE:PLX) Q4 2020 Earnings Conference Call March 30, 2021 8:30 AM ET Company Participants David Holmes - LifeSci Advisors Dror Bashan - President and Chief Executive Officer Eyal Rubin - Senior Vice President and Chief Financial Officer Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright & Co. John Vandermosten - Zacks Investments Operator Good morning, ladies and gentlemen, and welcome to Protalix BioTherapeutics’ Fiscal Year 2020 Earnings Conference Call. ...

Washington, D.C. 20549 FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION FOR ANNUAL AND TRANSITION REPORTS PURSUANT TO SECTIONS 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-33357 (Commission file number) P ...

Protalix BioTherapeutics, Inc. (NYSE:PLX) Q3 2020 Results Conference Call October 29, 2020 8:30 AM ET Company Participants Chuck Padala - LifeSci Advisors, Investor Relations Dror Bashan - President & Chief Executive Officer Eyal Rubin - Chief Financial Officer Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright Operator Greetings and welcome to the Protalix Biopharmaceuticals Third Quarter 2020 Financial Results and Business Update. At this time all participants are in a listen-only mode. ...

Protalix BioTherapeutics, Inc. (NYSE:PLX) Q2 2020 Results Earnings Conference Call August 10, 2020 8:30 AM ET Â Company Participants Chuck Padala - LifeSci Advisors, Investor Relations Dror Bashan - President and CEO Eyal Rubin - Chief Financial Officer Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright Operator Good morning, ladies and gentlemen. And welcome to the Protalix BioTherapeutics Second Quarter 2020 Earnings Call. As a reminder, this conference is being recorded. I would now lik ...

Protalix Bio Therapeutics (NYSE:PLX) Q1 2020 Earnings Conference Call June 1, 2020 8:30 AM ET Company Participants Dror Bashan - President, Chief Executive Officer Eyal Rubin - Senior Vice President, Chief Financial Officer Chuck Padala - Investor Relations Conference Call Participants Boobalan Pachaiyappan - HC Wainwright Philippa Gardner - Jefferies Walter Goering - private investor Operator Greetings and welcome to the Protalix Bio Therapeutics first quarter 2020 earnings conference call. At this time, a ...

Protalix BioTherapeutics, Inc. (NYSE:PLX) Q4 2019 Earnings Conference Call March 12, 2020 8:30 AM ET Company Participants Monique Kosse - IR, LifeSci Advisors Dror Bashan - President & CEO Eyal Rubin - CFO Conference Call Participants Boobalan Pachaiyappan - H.C. Wainwright Peter Welford - Jefferies Operator Greetings and welcome to the Protalix Biopharmaceuticals reports Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call. At this time, all participants are in a listen-only mod ...

Protalix BioTherapeutics, Inc. CORPORATE UPDATE | FEBRUARY 2020 Note Regarding Forward-Looking Statements This presentation (the "Presentation") contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements, including, among others, statements regarding expectations as to regulatory approvals, market opportunity for, and potential sales of, the Company's product and product candid ...

Protalix BioTherapeutics, Inc. CORPORATE UPDATE | FEBRUARY 2020 Note Regarding Forward-Looking Statements This presentation (the "Presentation") contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements, including, among others, statements regarding expectations as to regulatory approvals, market opportunity for, and potential sales of, the Company's product and product candid ...

Protalix BioTherapeutics, Inc. (NYSE:PLX) Q3 2019 Earnings Conference Call November 7, 2019 8:30 AM ET Company Participants Dror Bashan - President and Chief Executive Officer Eyal Rubin - Senior Vice President and Chief Financial Officer Conference Call Participants Operator Good day. And welcome to the Protalix Biotherapeutics Third Quarter 2019 Earnings Call. Today's call is being recorded. At this time, I'd like to turn the conference over to [Mani Kasi] of LifeSci Advisors. Please go ahead. Unidentifie ...

Protalix Biotherapeutics, Inc. (NYSE:PLX) Q2 2019 Earnings Conference Call August 8, 2019 8:30 AM ET Company Participants Dror Bashan - President & CEO Conference Call Participants Edward Marks - H.C. Wainwright & Co. Peter Welford - Jefferies Operator Good morning ladies and gentlemen and welcome to the Protalix Second Quarter 2019 Financial Results and Corporate Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question and answer session and instructions wi ...